Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Dougados

Showing results (461-470 of 600) with videos related to

Pageof 60
Sort By:
Rheumatology and Therapy|August 21, 2020
Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 WeeksHelena Marzo-Ortega, Philip J Mease, Proton Rahman, et al.
RMD Open|May 17, 2018
Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic disease-modifying antirheumatic drugsDesirée van der Heijde, Maxime Dougados, Ying-Chou Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritisValérie Devauchelle, Abdellatif Essabbani, Gonzague De Pinieux, et al.
Lancet (London, England)|July 27, 2020
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trialGerd R Burmester, Frank Buttgereit, Corrado Bernasconi, et al.
Annals of the Rheumatic Diseases|June 4, 2018
Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA studySantiago Rodrigues Manica, Alexandre Sepriano, Sofia Ramiro, et al.
RMD Open|November 14, 2020
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature researchAndreas Kerschbaumer, Josef S Smolen, Peter Nash, et al.
The Journal of Rheumatology|April 3, 2010
Reproducibility of joint swelling assessments in long-lasting rheumatoid arthritis: influence on Disease Activity Score-28 values (SEA-Repro study part I)Thierry Marhadour, Sandrine Jousse-Joulin, Gérard Chalès, et al.
Joint Bone Spine|May 13, 2006
Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinionThao Pham, Laure Gossec, Arnaud Constantin, et al.
Annals of the Rheumatic Diseases|August 12, 2010
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: methodological report phase IJulia Funovits, Daniel Aletaha, Vivian Bykerk, et al.
Joint Bone Spine|July 3, 2016
Collection and management of selected comorbidities and their risk factors in chronic inflammatory rheumatic diseases in daily practice in FranceLaure Gossec, Athan Baillet, Sabrina Dadoun, et al.
Pageof 60

Showing results (461-470 of 600) with videos related to

Sort By:
Pageof 60
Rheumatology and Therapy|August 21, 2020
Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 WeeksHelena Marzo-Ortega, Philip J Mease, Proton Rahman, et al.
RMD Open|May 17, 2018
Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic disease-modifying antirheumatic drugsDesirée van der Heijde, Maxime Dougados, Ying-Chou Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritisValérie Devauchelle, Abdellatif Essabbani, Gonzague De Pinieux, et al.
Lancet (London, England)|July 27, 2020
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trialGerd R Burmester, Frank Buttgereit, Corrado Bernasconi, et al.
Annals of the Rheumatic Diseases|June 4, 2018
Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA studySantiago Rodrigues Manica, Alexandre Sepriano, Sofia Ramiro, et al.
RMD Open|November 14, 2020
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature researchAndreas Kerschbaumer, Josef S Smolen, Peter Nash, et al.
The Journal of Rheumatology|April 3, 2010
Reproducibility of joint swelling assessments in long-lasting rheumatoid arthritis: influence on Disease Activity Score-28 values (SEA-Repro study part I)Thierry Marhadour, Sandrine Jousse-Joulin, Gérard Chalès, et al.
Joint Bone Spine|May 13, 2006
Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinionThao Pham, Laure Gossec, Arnaud Constantin, et al.
Annals of the Rheumatic Diseases|August 12, 2010
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: methodological report phase IJulia Funovits, Daniel Aletaha, Vivian Bykerk, et al.
Joint Bone Spine|July 3, 2016
Collection and management of selected comorbidities and their risk factors in chronic inflammatory rheumatic diseases in daily practice in FranceLaure Gossec, Athan Baillet, Sabrina Dadoun, et al.
Pageof 60